ZENATANE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Zenatane, and what generic alternatives are available?
Zenatane is a drug marketed by Dr Reddys Labs Ltd and is included in one NDA.
The generic ingredient in ZENATANE is isotretinoin. There are thirteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the isotretinoin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zenatane
A generic version of ZENATANE was approved as isotretinoin by AMNEAL PHARMS NY on September 29th, 2017.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ZENATANE?
- What are the global sales for ZENATANE?
- What is Average Wholesale Price for ZENATANE?
Summary for ZENATANE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 73 |
| Clinical Trials: | 9 |
| Patent Applications: | 7,499 |
| Drug Prices: | Drug price information for ZENATANE |
| Drug Sales Revenues: | Drug sales revenues for ZENATANE |
| DailyMed Link: | ZENATANE at DailyMed |
Recent Clinical Trials for ZENATANE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Children's Oncology Group | Phase 2 |
| National Cancer Institute (NCI) | Phase 2 |
| National Cancer Institute (NCI) | Phase 1 |
Pharmacology for ZENATANE
| Drug Class | Retinoid |
US Patents and Regulatory Information for ZENATANE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dr Reddys Labs Ltd | ZENATANE | isotretinoin | CAPSULE;ORAL | 202099-001 | Mar 25, 2013 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Dr Reddys Labs Ltd | ZENATANE | isotretinoin | CAPSULE;ORAL | 202099-003 | Mar 25, 2013 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Dr Reddys Labs Ltd | ZENATANE | isotretinoin | CAPSULE;ORAL | 202099-002 | Mar 25, 2013 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Dr Reddys Labs Ltd | ZENATANE | isotretinoin | CAPSULE;ORAL | 202099-004 | Feb 23, 2015 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
